Free Trial

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Down 25.3% in August

Shionogi & Co., Ltd. Unsponsored ADR logo with Medical background

Key Points

  • Short interest in Shionogi & Co., Ltd. Unsponsored ADR decreased by 25.3% in August, dropping to 52,200 shares from 69,900 in July.
  • The company reported $0.16 earnings per share for its last quarter, exceeding analysts' expectations of $0.14, despite revenues of $672.90 million falling short of estimates.
  • Shionogi's stock performance reflects a 1-year low of $6.53 and a high of $9.14, with the current stock price at $8.99.
  • Five stocks we like better than Shionogi & Co., Ltd. Unsponsored ADR.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) was the recipient of a large decrease in short interest in August. As of August 15th, there was short interest totaling 52,200 shares, a decrease of 25.3% from the July 31st total of 69,900 shares. Based on an average trading volume of 199,500 shares, the short-interest ratio is presently 0.3 days. Based on an average trading volume of 199,500 shares, the short-interest ratio is presently 0.3 days.

Shionogi & Co., Ltd. Unsponsored ADR Stock Down 1.1%

Shares of OTCMKTS:SGIOY traded down $0.10 during trading on Friday, hitting $8.95. The stock had a trading volume of 50,649 shares, compared to its average volume of 71,257. Shionogi & Co., Ltd. Unsponsored ADR has a 12 month low of $6.53 and a 12 month high of $9.14. The company has a market capitalization of $15.23 billion, a PE ratio of 15.29, a PEG ratio of 2.05 and a beta of 0.20. The firm's fifty day moving average is $8.68 and its 200 day moving average is $8.28. The company has a quick ratio of 6.13, a current ratio of 6.63 and a debt-to-equity ratio of 0.01.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last announced its earnings results on Monday, July 28th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.02. The firm had revenue of $672.90 million during the quarter, compared to the consensus estimate of $719.55 million. Analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

(Get Free Report)

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.

Featured Articles

Should You Invest $1,000 in Shionogi & Co., Ltd. Unsponsored ADR Right Now?

Before you consider Shionogi & Co., Ltd. Unsponsored ADR, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shionogi & Co., Ltd. Unsponsored ADR wasn't on the list.

While Shionogi & Co., Ltd. Unsponsored ADR currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.